Vensana Capital
Edit

Vensana Capital

https://www.vensanacap.com/
Last activity: 21.08.2026
Active
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with
Likes
141
Portfolio
6
Mentions
21
Employees: 1-10
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Series B; Series C

Portfolio 6

DateNameWebsiteTotal RaisedLocation
22.07.2026TYBR Healt...tybrhealth.com$30MUnited Sta...
08.01.2026Apellaapella.io$101MUnited Sta...
23.11.2025Okami Medi...okamimedical.com$84.7MUnited Sta...
10.07.2023SpyGlass P...spyglasspharma.com$165MUnited Sta...
25.07.2022Cleerlycleerlyhealth.com$372MUnited Sta...
09.06.2022Moxemoxehealth.com$60.5MUnited Sta...

Mentions in press and media 21

DateTitleDescription
21.08.2026Intuitive Machines lands $600M satellite deal, NASA ‘spacecraft bus’ contractHouston-based space infrastructure company Intuitive Machines has scored two astronomical deals. The deals add to the company’s soaring success. As of June 30, Intuitive Machines had a record-high $1.8 billion backlog of orders, a $1.5 bill...
18.08.2026Tech giant Apple opens Advanced Manufacturing Center at massive Houston facilityCupertino, California-based Apple Inc. unveiled its Advanced Manufacturing Center in the Houston area last week, marking the completion of the second of three facilities the tech giant plans to launch in the city by the end of this year. Th...
27.07.2026TYBR Health Secures $30 Million to Revolutionize Surgical HealingTYBR Health secured $30 million Series A funding. This investment fuels the B3 GEL System. The FDA-cleared hydrogel protects healing tissue post-orthopedic surgery. It focuses on biological recovery. Funding expands commercial access and su...
22.07.2026TYBR Health Raises $30 Million Series A To Expand B3 GEL SystemTYBR Health has raised $30 million in Series A financing to expand commercial access to its B3 GEL System, pursue additional product indications and conduct clinical studies involving tissue protection following orthopedic surgery. Vensana ...
22.07.2026TYBR Health Raises $30M in Series A FundingTYBR Health, a Houston, TX-based company developing clinical improvement in post-operative tendon mobility, raised $30M in Series A funding. The round was led by Vensana Capital and Mutual Capital Partners, with participation from Neovate C...
08.01.2026The Automated OR: Apella Secures $80M to Scale Ambient Video Intelligence Across the Surgical SuiteWhat You Should Know – Apella has announced an $80M Series B round to scale its ambient AI platform designed for the most complex environment in the hospital: the operating room (OR). The round was led by HighlandX, with returning investors...
03.12.2025Okami Medical Secures $45M, Names New CEO for GrowthOkami Medical, a vascular tech firm, closed a $45M round. The funding will fuel expansion and innovation. Drew Hykes, ex-Inari Medical CEO, now leads Okami. Gilde Healthcare led the round, joining the board. Okami Medical, a California-base...
01.12.2025Okami Medical: $45 Million In New Funding Raised And New CEO AppointedOkami Medical has closed an oversubscribed $45 million financing round led by new investor Gilde Healthcare, with participation from existing backers Vensana Capital and U.S. Venture Partners. The company plans to deploy the capital to expa...
23.11.2025Okami Medical: $45 Million Raised And New CEO Appointed To Accelerate Commercial And Clinical ExpansionOkami Medical has closed an oversubscribed $45 million financing round and appointed a new chief executive as the company prepares for its next phase of commercial growth and product innovation. The round was led by new investor Gilde Healt...
26.03.2025Evident Vascular Secures Series B Funding to Revolutionize Intravascular ImagingIn the bustling world of medical technology, innovation is the lifeblood. Evident Vascular, a San Jose-based company, has just injected a fresh dose of capital into its veins. On March 25, 2025, the company announced the successful closing ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In